| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 2.41▲ | 2.42▼ | 2.42▼ | 2.48▼ | 2.46▼ |
| MA10 | 2.41▲ | 2.43▼ | 2.45▼ | 2.46▼ | 2.96▼ |
| MA20 | 2.42▼ | 2.45▼ | 2.48▼ | 2.50▼ | 3.49▼ |
| MA50 | 2.45▼ | 2.47▼ | 2.43▼ | 3.16▼ | 4.69▼ |
| MA100 | 2.45▼ | 2.43▼ | 2.45▼ | 3.59▼ | 4.40▼ |
| MA200 | 2.49▼ | 2.47▼ | 2.69▼ | 4.55▼ | 3.50▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.001▲ | -0.005▼ | -0.011▼ | 0.045▲ | -0.103▼ |
| RSI | 45.618▼ | 41.962▼ | 44.373▼ | 36.032▼ | 27.919▼ |
| STOCH | 47.222 | 13.841▼ | 20.459 | 51.059 | 7.007▼ |
| WILL %R | -50.000 | -86.957▼ | -88.462▼ | -64.371 | -92.876▼ |
| CCI | 6.422 | -91.536 | -129.220▼ | -5.253 | -90.937 |
|
Tuesday, May 19, 2026 05:00 PM
Oppenheimer analyst Leland Gershell maintains Protara Therapeutics (NASDAQ:TARA) with a Outperform and raises the price target from $25 to $28. JP Morgan analyst Brian Cheng maintains Protara ...
|
|
Tuesday, February 24, 2026 07:23 AM
Protara Therapeutics (NASDAQ:TARA) on February 23, 2026, announced updated interim data from its ongoing Phase 2 ADVANCED-2 trial evaluating intravesical TARA-002 in patients with high-risk non-muscle ...
|
|
Thursday, December 04, 2025 04:30 AM
Protara Therapeutics maintains strong momentum with TARA-002, showing durable, high complete response rates in NMIBC and promising efficacy in lymphatic malformations. TARA-002’s 6-month complete ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 02/11/26 | 2.48 | 2.515 | 2.40 | 2.415 | 147,955 |
| 30/10/26 | 2.51 | 2.57 | 2.43 | 2.48 | 580,926 |
| 29/10/26 | 2.52 | 2.625 | 2.50 | 2.52 | 553,341 |
| 28/10/26 | 2.45 | 2.515 | 2.365 | 2.49 | 1,205,844 |
| 27/10/26 | 2.33 | 2.48 | 2.31 | 2.47 | 1,842,772 |
| 26/10/26 | 2.35 | 2.43 | 2.305 | 2.35 | 892,638 |
| 23/10/26 | 2.39 | 2.47 | 2.28 | 2.33 | 867,582 |
| 22/10/26 | 2.47 | 2.525 | 2.42 | 2.44 | 1,760,363 |
| 21/10/26 | 2.57 | 2.61 | 2.49 | 2.50 | 970,215 |
| 20/10/26 | 2.34 | 2.575 | 2.33 | 2.56 | 1,500,526 |
|
|
||||
|
|
||||
|
|